← Back to Search

STEPS Program for Autism

N/A
Recruiting
Research Sponsored by University of Alabama, Tuscaloosa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will study how to support emerging adults with autism to transition into adulthood. It will assess the effectiveness of a program delivered by community agencies.

Who is the study for?
This trial is for young individuals aged 16-25 with a confirmed diagnosis of Autism Spectrum Disorder (ASD) who are interested in participating in the STEPS program. They must also have a caregiver or parent available to complete assessments.Check my eligibility
What is being tested?
The trial is testing the STEPS support program, designed specifically for people with ASD, against standard services (SAU). It aims to see how well STEPS works when community agencies deliver it and what factors affect its success.See study design
What are the potential side effects?
Since this trial involves a support program rather than medication, traditional side effects are not applicable. However, participants may experience varying levels of comfort or stress during the intervention.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Transition Readiness Scale-Revised
Secondary outcome measures
Rehabilitation Success
Relationships, Employment, Autonomy, and Life Satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Group I: STEPSExperimental Treatment1 Intervention
14 session counseling targeting adult independence skills
Group II: ControlExperimental Treatment1 Intervention
Services as usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STEPS
2014
N/A
~270

Find a Location

Who is running the clinical trial?

University of Alabama, TuscaloosaLead Sponsor
44 Previous Clinical Trials
19,436 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
625 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to partake in this research endeavor?

"This research study is seeking 80 individuals diagnosed with Autism Spectrum Disorder between the ages of 16 and 25. Eligibility criteria include a confirmed ASD diagnosis, willingness to take part in STEPS activities, along with having a caregiver/parent who can complete assessments."

Answered by AI

Are there any opportunities for prospective participants to join this investigative endeavor?

"Yes, clinicaltrials.gov confirms that this study is currently recruiting patients since it was last edited on November 13th 2023. As of now, 80 people are expected to parttake in the trial from a single medical centre after its initial posting date of April 1st 2023."

Answered by AI

Does this study include any participants who are elderly?

"This medical research will accept participants between the ages of 16 and 25. Additionally, 254 clinical trials are available for individuals under 18 years old while 51 studies can be found to assist those over 65."

Answered by AI

What is the maximum capacity of participants for this clinical investigation?

"Affirmative, the clinical trial is still recruiting participants. According to its listing on clinicaltrials.gov, which was last updated November 13th 2023, this study requires 80 individuals from a single location since it began April 1st 2023."

Answered by AI
~37 spots leftby Apr 2025